BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 31359736)

  • 1. [Guidance of instructions for compiling expert consensus on clinical practice of Chinese patent medicine of China Association of Chinese Medicine].
    Mo M; Zhang XX; Liao X; Li B; Chen W; Zhao GZ; Guo YB
    Zhongguo Zhong Yao Za Zhi; 2019 Jun; 44(12):2652-2656. PubMed ID: 31359736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Reporting standards for expert consensus on clinical practice of Chinese patent medicines of China Association of Chinese Medicine].
    Mo M; Liao X; Zhang XX; Li B; Chen W; Zhao GZ; Guo YB
    Zhongguo Zhong Yao Za Zhi; 2019 Jun; 44(12):2644-2651. PubMed ID: 31359735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Technical specification for Instructions for Clinical Application of Chinese Patent Medicines in China Association of Chinese Medicine].
    Zhang XM; Sa RN; Zhang B; Zhang D; Lyu JT; Duan XJ; Lin ZJ; Guo YB
    Zhongguo Zhong Yao Za Zhi; 2021 Sep; 46(17):4563-4568. PubMed ID: 34581062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Manual for the clinical experts consensus of Chinese patent medicine].
    Fang SN; Guo YB; Liu JP; Liao X; Zhang XX; Mo M; Chen W
    Zhongguo Zhong Yao Za Zhi; 2018 Dec; 43(24):4786-4791. PubMed ID: 30717520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pre-searching during formulation of expert consensus on clinical application of Chinese patent medicines:Yanshen Jianwei Capsules as example].
    Feng X; Duan XJ; Sun JW; Guo YB
    Zhongguo Zhong Yao Za Zhi; 2021 Aug; 46(16):4287-4292. PubMed ID: 34467743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on method for formulating clinical practice guidelines of common Chinese patent medicines based on clinical practices].
    Liu BY; Liu B; He LY; Zhao YF; Bai WJ; Luo WS
    Zhongguo Zhong Yao Za Zhi; 2013 May; 38(9):1273-6. PubMed ID: 23944050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Discussion on issues related to clinical experts consensus of Chinese patent medicine].
    Fang SN; Sun SL; Guo YB; Liao X; Liu JP; Chen W
    Zhongguo Zhong Yao Za Zhi; 2018 Dec; 43(24):4792-4795. PubMed ID: 30717521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Editorial explanation for Expert consensus statement on Diemailing Kudiezi Injection in clinical practice].
    Liao X; Zhang YL; Xie YM; Shi DZ; Yu DD
    Zhongguo Zhong Yao Za Zhi; 2019 Sep; 44(17):3825-3829. PubMed ID: 31602959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expert consensus on prescription comment of Chinese traditional patent medicine for promoting the rational use of drugs in Beijing].
    Jin R; Zhao KJ; Guo GM; Zhang B; Wang YG; Xue CM; Yang YH; Wang LX; Li GH; Tang JF; Nie LX; Zhang XL; Zhao TT; Zhang Y; Yan C; Yuan SZ; Sun LL; Feng XZ; Yan D;
    Zhongguo Zhong Yao Za Zhi; 2018 Mar; 43(5):1049-1053. PubMed ID: 29676107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interpretation of Technical Specifications for Revision of Safety Information in Marketed Chinese Patent Medicine Instructions].
    Zhang XM; Lin ZJ; Zhang B; Sa RN; Lyu JT; Wu H; Li YL; Xu HZ; Huang ZK; Guo YB; Su XF; Duan XJ
    Zhongguo Zhong Yao Za Zhi; 2022 Jan; 47(2):295-300. PubMed ID: 35178970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Technical specifications for hospital-based intensive monitoring of post-marketing Chinese patent medicine].
    Xie YM; Liao X; Jiang JJ; Zhang YL; Ma R; Zhu MJ; Zhan SY; Liu JP; Liu J; Wen ZH; Yang ZQ; He Y; Li XL
    Zhongguo Zhong Yao Za Zhi; 2019 Jul; 44(14):2896-2901. PubMed ID: 31602831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expert consensus statement on Pudilan Xiaoyan Oral Liquid in clinical practice].
    Wang LX; Miao Q; Xie YM; Chen DC; Sun SL; Zhang HC; Jia ZW; Li TN; Zhu J; Shi LQ; Song P; Gao F; Wei BL; Feng CL; Qu YQ; Qu NN; Yu XF; Zhang NZ; Yu XQ
    Zhongguo Zhong Yao Za Zhi; 2019 Dec; 44(24):5277-5281. PubMed ID: 32237368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Series of group standards of Technical Specifications for Revision of Safety Information in Marketed Chinese Patent Medicine Instructions].
    Zhang B; Zhang XM; Lin ZJ; Sa RN; Lyu JT; Wu H; Li YL; Xu HZ; Huang ZK; Guo YB; Su XF; Duan XJ
    Zhongguo Zhong Yao Za Zhi; 2022 Jan; 47(2):285-294. PubMed ID: 35178969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Guidelines for post-marketing research on clinical effectiveness of Chinese patent medicines].
    Wang ZF; Xie YM; Tang JY; Zhang JH; Sun X; Yang ZQ
    Zhongguo Zhong Yao Za Zhi; 2024 Feb; 49(3):842-848. PubMed ID: 38621888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expert consensus statement on Kangfu Xiaoyan Suppository in treatment of pelvic inflammatory in clinical practice].
    Wang LX; Hou LH; Xie YM; Ma K; Sun SL; Jin Z; DU HL; Wang DM; Zhao H; Liu YF; Tang L; Shu KY; Zhang CZ; Shi W; Zhan SY; Liu JP; Chen W; Chen YL
    Zhongguo Zhong Yao Za Zhi; 2019 Oct; 44(20):4350-4353. PubMed ID: 31872644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experts consensus statement on Xiyanping Injection in clinical practice(children)].
    Wang ZF; Rong P; Ma R; Xie YM; Ding Y; Wang XF; Zhan SY; Li XH
    Zhongguo Zhong Yao Za Zhi; 2019 Jul; 44(14):2932-2936. PubMed ID: 31602835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Editorial explanation for clinical practice guideline for stable chronic obstructive pulmonary disease with traditional Chinese medicine].
    Yi-Ling F; Qing M; Xing L; Chang-Zheng F; Mao-Rong F; Qing C; Ning W; Qiu-Xiao MA; Ya-Ni H
    Zhongguo Zhong Yao Za Zhi; 2020 Nov; 45(22):5323-5330. PubMed ID: 33350191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Technical specification of expert consensus statement in developing clinical practice guidelines of traditional Chinese medicine].
    Liao X; Xie YM; Zhang JH; Liu QQ; Ma R; Wang YX; Miao Q; Zhang HC; Li GX; Ma K; Chen YL; Chen W; Hu J
    Zhongguo Zhong Yao Za Zhi; 2019 Oct; 44(20):4354-4359. PubMed ID: 31872645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interpretation of Expert consensus on Shujin Jianyao Pills in clinical practice].
    Liu H; Gao JH; Xie YM; Li YY; Li SH; Zhang L; Xu ZJ; Huang F; Jin J; Li G
    Zhongguo Zhong Yao Za Zhi; 2020 Jul; 45(14):3336-3339. PubMed ID: 32726048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Registration and review of Chinese patent drugs in Kunming and the compilation and revision of the
    Yang ZQ
    Zhonghua Yi Shi Za Zhi; 2017 Jul; 47(4):213-221. PubMed ID: 28954363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.